Randomised trial of hyperimmune immunoglobulin in hospitalised COVID-19: pre-therapy Fc receptor binding SARS-CoV-2 antibody associated with better outcomes.
Year: 2026
Type: article
Source: PubMed
Institutions: The University of Melbourne, Peter Doherty Institute, UNSW Sydney, Kirby Institute, Australian National University, University of Minnesota, Icahn School of Medicine at Mount Sinai, Institute of Human Virology, MRC Clinical Trials Unit at UCL, University College London, Medical Research Council, University of Copenhagen, Copenhagen University Hospital, Gentofte Hospital, Australian Institute of Tropical Health and Medicine, James Cook University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7233593609
FWCI:
Cites:
Cited by:
Related to:
